Kevin is a recognized clinical research senior executive with more than 30 years of operational and business leadership experience, the last 20 years of which have been in the high-growth eClinical technology space. In his current role, Kevin is responsible for driving the growth strategy for the Randomization & Trial Supply Management (RTSM) business, encompassing Bioclinica’s innovative IRT platform, clinical supply forecasting, optimization and planning services, as well as further developing Bioclinica’s unique project delivery methodology. Prior to Bioclinica Kevin led the RTSM and clinical logistics solution business at PAREXEL Informatics. Before that, Kevin was with ClinPhone for ten years focused on RTSM and other eClinical solutions before being acquisition by PAREXEL in 2008. Kevin has lived in the USA since 1999 when he relocated from the United Kingdom to facilitate the establishment of ClinPhone’s business and North American operations. Prior to this he spent approximately ten years managing the execution of clinical development plans for various multinational pharmaceutical companies spanning all stages of pre-clinical and clinical research. Kevin has a Bachelor’s degree in Physiology and Pharmacology from the University of Southampton (UK).